Although emergency contraception (EC) is safe, effective, and widely available, misinformation communicated by pharmacies to adolescents and their physicians can make it difficult for teens to obtain EC in a timely manner. Do you know how to counter the misinformation and help your patients access EC?
Although emergency contraception (EC) is safe, effective, and widely available, misinformation communicated by pharmacies to adolescents and their physicians can make it difficult for teens to obtain EC in a timely manner.
Since 2009, EC has been available without prescription to women aged 17 years or older. It is estimated that if EC were used after every contraception failure, it could prevent half of all unintended pregnancies and 70% of all abortions. Timely access is critical, however, because every 12-hour delay in taking EC increases the odds of pregnancy by 50%.
To determine the accuracy of information provided to adolescents and their physicians, researchers made scripted phone calls to commercial pharmacies in 5 major US cities. Each pharmacy received 2 calls from female callers posing as either a 17-year-old girl who had had unprotected intercourse or a physician caring for such a patient.
Of 943 pharmacies, 759 (80%) told adolescent callers and 766 (81%) told physician callers that EC was available on the day of the call. Nonetheless, 19% of adolescent callers were told that they could not obtain EC under any circumstances. In contrast, only 3% of physicians calling on behalf of their patients were given this misinformation.
Nearly half of all pharmacies gave incorrect information to both adolescents and physicians inquiring about the age threshold for access to EC without a prescription. Adolescents were put on hold twice as often as physicians and spoke to self-identified pharmacists less often. When EC was not available, 36% of pharmacies called by adolescents and 33% of those called by physicians offered no suggestions on how to obtain it.
The researchers say that to eliminate access barriers to obtaining EC over the counter, further education about EC dispensing rules is needed for pharmacy staff, physicians, and adolescents.
Last December, the US Secretary of Health and Human Services overruled a US Food and Drug Administration recommendation to remove EC prescription requirements for all girls of reproductive age.
Prehospital medication dosing deviates from recommended weight-based guidelines
July 20th 2023Lorazepam, diazepam, midazolam, fentanyl, hydromorphone, morphine, ketorolac, epinephrine, diphenhydramine, and methylprednisolone were investigated in the study. Overall, the most common type of deviation was an underdose.
Having "the talk" with teen patients
June 17th 2022A visit with a pediatric clinician is an ideal time to ensure that a teenager knows the correct information, has the opportunity to make certain contraceptive choices, and instill the knowledge that the pediatric office is a safe place to come for help.
Does stimulant medication for pediatric ADHD affect adult height?
November 8th 2022A recent review found that multiple clinical trials indicated a reduction in adult height potential for children with long-term use of stimulant medication for treatment of ADHD, but other studies conflict with this data.
Diagnosing and treating the adolescent with irregular menstruation
October 10th 2022At the 2022 AAP National Conference & Exhibition, a professor from the Baylor College of Medicine discusses how to develop an approach to investigate menstrual disturbances for adolescent patients and understand treatment options.